205 related articles for article (PubMed ID: 19692815)
1. A rare presentation of metastatic renal clear cell carcinoma to the tongue seen on FDG PET.
Basely M; Bonnel S; Maszelin P; Verdalle P; Bussy E; de Jaureguiberry JP
Clin Nucl Med; 2009 Sep; 34(9):566-9. PubMed ID: 19692815
[TBL] [Abstract][Full Text] [Related]
2. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
Ramdave S; Thomas GW; Berlangieri SU; Bolton DM; Davis I; Danguy HT; Macgregor D; Scott AM
J Urol; 2001 Sep; 166(3):825-30. PubMed ID: 11490227
[TBL] [Abstract][Full Text] [Related]
3. Better late than early: FDG-PET imaging in metastatic renal cell carcinoma.
Harrison MR; George DJ
Clin Cancer Res; 2011 Sep; 17(18):5841-3. PubMed ID: 21926167
[TBL] [Abstract][Full Text] [Related]
4. Sarcomatoid renal cell carcinoma: rapid dissemination detected on FDG PET-CT.
Thambugala GM; Mohamed A; O' Neill GF; Fulham MJ
Australas Radiol; 2006 Dec; 50(6):604-6. PubMed ID: 17107535
[TBL] [Abstract][Full Text] [Related]
5. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
Park JW; Jo MK; Lee HM
BJU Int; 2009 Mar; 103(5):615-9. PubMed ID: 19007371
[TBL] [Abstract][Full Text] [Related]
6. Does F-18 FDG-PET still play a role in metastatic renal cell carcinoma?
Mennitto A; Grassi P; Verzoni E; Ratta R; Procopio G
J Med Imaging Radiat Oncol; 2017 Apr; 61(2):250-251. PubMed ID: 28070961
[No Abstract] [Full Text] [Related]
7. Comparison of 18F-DCFPyL and 18F-FDG PET/computed tomography for the restaging of clear cell renal cell carcinoma: preliminary results of 15 patients.
Liu Y; Wang G; Yu H; Wu Y; Lin M; Gao J; Xu B
Nucl Med Commun; 2020 Dec; 41(12):1299-1305. PubMed ID: 32941403
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma.
Jadvar H; Kherbache HM; Pinski JK; Conti PS
Clin Nephrol; 2003 Dec; 60(6):395-400. PubMed ID: 14690256
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT in a patient affected by renal collecting duct (Bellini) carcinoma.
Bertagna F; Fisogni S; Tardanico R; Simeone C; Cunico SC; Giubbini R
Clin Nucl Med; 2012 Oct; 37(10):986-8. PubMed ID: 22955073
[TBL] [Abstract][Full Text] [Related]
10. Lesion detection by [
Verhoeff SR; van Es SC; Boon E; van Helden E; Angus L; Elias SG; Oosting SF; Aarntzen EH; Brouwers AH; Kwee TC; Heskamp S; Hoekstra OS; Verheul H; van der Veldt AAM; de Vries EGE; Boerman OC; van der Graaf WTA; Oyen WJG; van Herpen CML
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1931-1939. PubMed ID: 31172212
[TBL] [Abstract][Full Text] [Related]
11. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma.
Majhail NS; Urbain JL; Albani JM; Kanvinde MH; Rice TW; Novick AC; Mekhail TM; Olencki TE; Elson P; Bukowski RM
J Clin Oncol; 2003 Nov; 21(21):3995-4000. PubMed ID: 14581422
[TBL] [Abstract][Full Text] [Related]
12. Unusual metastatic sites from renal cell carcinoma detected by 18F-FDG PET/CT scan.
Aurangabadkar H; Ali Z
Clin Nucl Med; 2013 Dec; 38(12):e471-3. PubMed ID: 23603603
[TBL] [Abstract][Full Text] [Related]
13. Isolated Nasal Metastasis From Renal Cell Carcinoma 9 Years After Nephrectomy Seen on FDG PET.
Yao Y; Zuo Z; Cheng Z
Clin Nucl Med; 2020 Feb; 45(2):e110-e111. PubMed ID: 31714277
[TBL] [Abstract][Full Text] [Related]
14. PET scans for decision-making in metastatic renal cell carcinoma: a single-institution evaluation.
Dilhuydy MS; Durieux A; Pariente A; de Clermont H; Pasticier G; Monteil J; Ravaud A
Oncology; 2006; 70(5):339-44. PubMed ID: 17164590
[TBL] [Abstract][Full Text] [Related]
15. FDG PET/CT of Chromophobe Renal Cell Carcinoma With Sarcomatoid Differentiation.
Lee CH; Kesari V; Legesse T; Chen W
Clin Nucl Med; 2018 May; 43(5):367-369. PubMed ID: 29485439
[TBL] [Abstract][Full Text] [Related]
16. [Malignant tumor with false negative 18F-FDG PET image].
Dong MJ; Lin XT; Zhao J; Guan YH; Zuo CT; Chen X; Dai JZ; Jiang BD
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):713-7. PubMed ID: 17274383
[TBL] [Abstract][Full Text] [Related]
17. Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma.
Karivedu V; Jain AL; Eluvathingal TJ; Sidana A
Curr Urol Rep; 2019 Aug; 20(10):56. PubMed ID: 31468240
[TBL] [Abstract][Full Text] [Related]
18. 68Ga-PSMA PET/CT and 18F-FDG PET/CT in Renal Cell Carcinoma.
Chen EJ; Tan TH; Chew MT; Chye PC
Clin Nucl Med; 2020 Jul; 45(7):e317-e319. PubMed ID: 32404702
[TBL] [Abstract][Full Text] [Related]
19. Enhanced MRI and 18F-FDG PET/CT Findings of Preoperative Primary Renal Collecting Duct Carcinoma.
Ge J; Zuo C; Guan Y; Liang Z
Clin Nucl Med; 2016 Dec; 41(12):998-999. PubMed ID: 27775947
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular myocardium metastasis in a patient with primary renal cell carcinoma detected by 18F-FDG PET/CT.
Pinnamaneni N; Muthukrishnan A
Clin Nucl Med; 2012 Jul; 37(7):e181-3. PubMed ID: 22691531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]